Annual report pursuant to Section 13 and 15(d)

Other current assets (Tables)

v3.24.0.1
Other current assets (Tables)
12 Months Ended
Dec. 31, 2023
Other current assets  
Summary of other current assets

Other current assets consisted of the following (in thousands):

December 31, 

December 31, 

    

2023

    

2022

Research and development credits receivable

 

$

46,098

$

30,162

Prepayments

 

9,954

9,472

Clinical materials

 

1,329

1,279

VAT receivable

490

Other current assets

 

2,412

1,927

$

59,793

$

43,330